This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 859c2746-20f3-47a6-a96e-a1e41453
Researchers at the University of Sydney and University of Geneva have developed a new anticoagulant, whose anticlotting action can be rapidly stopped ‘on demand’. The result could lead to new
Graphical abstract. Credit: Journal of Clinical Investigation (2024). DOI: 10.1172/JCI175447 A cellular link between obesity and atrial fibrillation—a heart condition that afflicts over 33 million people worldwide—presents a promising target
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ventricular (LV) diastolic function, according to a study published online Sept. 9 in Circulation: Heart
